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This study w as focused on the characterization of the 
m etabolism of linoleic acid by human dermal fibro-
blasts and the effect of interleukin- l on the biosyn-
thesis of octadecanoids. Dermal fibroblasts untreated 
and tre ated with recombinant IL-lf3 were incubated 
with exogenous labeled linoleic acid. A combination 
of high performance liquid chromatography and gas 
chromatography-mass spectrometry was used as the 
analytic technique. We found that dermal fibroblasts 
convert linole ic a cid mainly into 13-hydroxy-9- cis,11-
trails-octadecadienoic acid (13-HODE) and 9-hy-
droxy-l 0-tralls,12-cis-octadecadienoic acid (9-HODE), 
13(S)-HODE and 9(R)-HODE being the predominant 
enantiomers. IL-lf3 increased the formation of both 
13-HODE and 9-HODE in a concentration-dependent 
manner with similar ECso values as for prostanoid 
formation. This effect of IL-lf3 on HODEs formation 
was concomitant with the expression of prostaglandin 
Linoleic acid (LA) is an essential CiS-.POIYU. nsa turated fatty ac id and the precursor o f 13- and 9-hydroperoxy-octadecad ienoic (HPODE) acids, which in turn are reduced to the corresponding hydroxy-octadecadienoic (HODE) acids, these being the majo r oxygenated 
metabolites of LA p roduced by cells. HPO DEs and H O D Es have 
been fo und in high am ounts in atherosclerotic (Kiirm , 1992) and 
psoriatic lesions (Camp cf al.,1 983; Bae r el. ai, 1990, 1991) and have 
several biologic acti viti es involved in the inflammatory response 
(Buchanan el ai, 1985; Yamaj a Setty el ai , 1987; Iversen et ai , 199 1; 
K u cl ai, 1992). 
T he site of oxygen insertion on LA is primarily at the C9 or C 13 and 
is largely dependen t on the cell type. In general, enzymatic oxidation 
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H-synthase-2. Formation of octadecanoids was inhib-
ited in a concentration-dependent manner by acetylsal-
icylic acid and indomethacin. Dexamethasone, actino-
mycin D, and cycloheximide abolished the effect o f 
IL-lf3 on HODEs biosynthesis. Octadecanoid biosyn-
thetic activity was associated with the micro somal frac-
tion. Dermal fibroblasts incorporated [14C)_9_HODE 
and [14C)-13-HODE into phospholipids, mainly into 
phosphatidylcholine. IL-lf3 increased significantly the 
esterification of 13-HODE in all glycerophospholipids, 
the major increase being observed in phosphatidylino-
sitol. These results indicate that prostaglandin H-syn-
thase-2 is the enzyme responsible for the increase in the 
ability to form HODEs of dermal fibroblasts stimulated 
with IL-lf3. Key words: hydroxy-octa.decadiello ic acidlcytokillel 
cyc1ooxyge"aselplrospllolipid. ] l,west Derlllatol 107:726- 732, 
1996 
of LA may involve both prostaglandin H synthase (pGHS) and 
15-lipo" .. ygenase (1 5-LO) activities (Hamberg and Samuelsson, 1967; 
R einaud ef ai, 1989), which are differentially expressed. Biosynthesis of 
HPODEs and H O DEs has been reported to occur in several cells 
including vascular (Buchanan eJ ai, 1985; Cam acho el ai, 1995) and 
epidemlal (N ugteren and Kivi ts, 1987) cells, platelets (Daret et ai, 
1989), and leukocytes (Reinaud et ai, 1989) , but the precise biosyn-
thetic pathway is often not w ell established. 
A charac ter istic feature in the immune response is the coop-
eration be tween cytokin es and lipid m edi ators in the regulation 
of inflammatory and pro life rati ve responses . Inte rleukin-l (IL- 1) 
is a pl eiotropic cyto kine that plays a central rol e in inflammation. 
IL-1 induces the expression o f adhesion m olecules and second-
ary cytokin es w hich , in turn, induce acute and ch ronic inflam-
m atory changes (Dinare llo, 1991) . IL-l also stimulates the 
release of prostaglandin s and promo tes the expression of pros-
taglandin H-synthase (PGHS) (Raz el ai, 1988; M aier el ai, 
1990) . Two PGHS isoenzym es encoded by different genes have 
been characterized : PGHS-1 is expressed in a constitu tive 
manner and PGHS-2 is the indu cible isoe nzym e by mitogens, 
which is o verexpressed in many infl amm ato ry processes (Smith, 
1992; Hl a etat, 1993). 
D ermal fibrobl asts are able to release fac tors that may control the 
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aC tiVIty of the epidermis, such as cytokines (Larson e( nl, 1989; 
Kupper, 1990), and also eicosanoids such as prostaghllldin E2 
(PGE2) or 15-hydro}.:yeicosatetraenoic acid (Mayer e/ al. 1984). We 
reported that IL-1 increase d the ability of dermal fibroblasts to form 
15-hydro;\.'yeicosatetraenoic acid and that tlus was due to an 
increase of PGHS activity rather than to an enhanced 1s-LO 
activity (Godessart e/ ai, 1994). Nevertheless, the expression of the 
twO isoenzymes of the PGHS was not evaluated at that time. 
Because IL-1 is a central mediator in the inAammatory response on 
skin and because HPODEs and HODEs playa modulatory role in 
inflammatory and proliferative responses, we wished to investigate 
the ITletaboLis111 of LA in dermal fibroblasts, the effect ofIL-l on it, 
and the enzyme involved in that effect. 
MATERJALS AND METHODS 
Fibroblast Isolation and Culture Cells were isolated &om skin samples 
of breast and abdomen of women w ho had undcrgone plastic surgery. 
Dennis and epidermis were separated according to the teclmique described 
by Liu and Karasek (1978). The fragments of the dermis were then 
incubated overnight in complete culture mcdium [Dulbecco's modified 
Eagle's medium (DMEM)l containing 10% feta l bovine serum (Bio-Whit-
taker, Walkersville, MD) and 0.5 mg collagenase Type [a per 1111 (Boehr-
inger Mannheim S.A., Barcelona, Spain). The suspension was filtered 
through sterile gauze, collected by centrifugation, and seeded ill 75-cm2 
culture flasks at a density of 106 cells/flask. When the cu lture reached 
confluence, cells were released with 0.2% trypsin and split at a ratio of 1:3. 
Cells were detached and seeded in six-well plates at a density of 1 05 ce lls per 
mJ and used at confluence (6-7 .105 cells/well) . All experiments were 
performed with cells between passages 5 to 7. 
Incubations of Fibroblasts with [14C]LA Confluent cells in six-well 
plates were incubated at 37°C in the presence of 0.4 ml meditilll containing 
10 rn.M HEPES, 2 mM CaCI2 • and the indicated concentration of ['·CJLA 
(50 -53 mCi/mmol, DuPont NEN, Boston, MA) in 5 fLl of ethanol. After 
the indicated periods of time . the reactions were stopped by addition of 1 N 
Hel to yield a pH of 3 fo llowed by one volume of cold methanol. Samples 
were kcpt at -BO°C until ana lysis. 
Nonenzymatic fOn1lation of HODEs was estimated by incubating 
["ClLA with boiled cells. 
Analysis of Octadecanoids Straight-phasc-high performance liquid 
chromatography (SP-HPLC), gas chromatography-mass spectrometry (GC-
MS), a nd chiml analysis were performed essentially as described previously 
(Camacho et nl, 1995). 
Incubations with IL-l/3 Fibroblasts were incubated for the indicated 
times with 1 1111 ofDMEM containing 1% (vo l/vol) fetal bovine serum and 
0-20 U human recombinant IL-1 {3 (Boehringer Manheim, Indianapolis, IN) 
per tn.l. Medium was removed, and the cells werc washed with 2 ml of 0.1 
M phosphate-buffered saline (0 .1 6 M NaCl, pH 7.4). Cells were thell 
incubated with ["ClLA, as described, or disrupted for RNA extraction. 
PGHS-l and -2 Specific mRNA Analysis Total RNA was isolated by 
phenol- chloroform extraction and isopropanol precipitation according to 
the protocol described by Chomczynski and Sacchi (1987) and quantitated 
5pectrophotometrical.l y by absorption at 260 and 2BO 11m. The specific 
mR.NA levels ,vcre cstilnatcd by Incans of a quantitative reverse tra.n-
. criptase-polymerase cbain reaction protocol: briefly, 1 fLg of total RNA 
was reverse transcribed in to cDNA by incubation with 50 U of murine 
leukemia virus reverse transcriptasc in a reaction buffer conta.ining 10 111M 
T ri5(hydroxymethyl) -aminomethane-HCI, pH 8.3, 50 mM KCI. 5 mM 
MgC12 , 2.5 fLM random hexamers, 20 U of R.nasin (GeneAmp RNA 
polym erase chain reaction kit, Perkin-Elmer, Branchburg, NJ) , and 1 mM 
deoxynucleoside triphosphates (Epicentre TcclUlo logies, Madison , W I) in a 
fin ru volume of20 fLl. The reaction mi;"ture was incubated 30 min at 42°C, 
and the reaction was stopped by heating 5 min at 99°C and then 5 min at 
5°C . 
The primers used for PGHS-1 and PGHS-2 were 5'-TGCCCAGCT-
CCTGGCCCGCCGCTT-3' (sense) and 5' -GTGCA TCAACACAGGCGC-
CTCTTC-3 ' (anti-sense) and 5'-TTCAAATGAGATTGTGGGAAAATT-
GCT- 3' (sense) and 5'-AGATCATCTCTGCCTGAGTATCTT-3 ' 
(anti- sense), respectively (Hla and Neilson, 1992). The RNA for glyceralde-
hyde-3-pbosphate-dehydrogenase was amplified and used as the internal 
control. The sense and anti-sense primers used for glyceraldehyde-3-phos-
phate-dehydrogenase were 5' -CCACCCATGGCAAA TTCCATGGCA-3' 
and 5 ' -TCTAGACGGCAGGTCAGGTCCACC-3', respectively (Maier et ai, 
1990). Polymcrase chain reaction was canied out in a DNA Themlal Cycler 
480 (perkin-Elmer) with a reaction I11Lxture (100 fLl) containing 10 mM 
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Tris(hydrQ)'J~llethyl)-aminomethane-HCI , pH 8.3, 50 mM KCl, 2.5 mM 
MgCI" 0.2 mM dem.:ynucleoside triphosphate. 1 fLM sense or anti-sense 
primers, 2.5 U Taq polymerase (Perkin-Elmer), and 4 fLCi of [' H]deo".'ycyti-
dine triphosphatc (48-71 Ci/mmol, Amersh:un Iberica, Madrid, Spain) . Serial 
half-dilutions of the cDNA were done in order to prove the linearity. Twenty 
seven cycles were perfornlcd as follows for all the sanlples: 1.5 min at 94°C, 1.5 
min at 58°C, and 1.5 min at 72°C. The products of the :unplification were 
separated in a 1.5% low melting point agarose gel (GIBCO BRL, Paisley, 
Scotland) containing etllidium bromide (0.5 fLg per ml, Perkin Elmer). To 
remove excess [' Hldeo"J,cytidine triphosphate and to avoid excessive back-
ground, when tile loading dye had migrated half way tlrrough thc gel. tile buJfer 
was replaced by a fi'esh one. The bands were visualized, cut out under 
ultraviolct (UV) light using a circular template, :Uld melted by heating to 70°C. 
Complete digestion of gel pieces was perfonned by adding 1 ml of tile tissue 
solubilizeI' NCS-Il (Amersham Iberica) and was left in a water batll at 50°C for 
'I h. Afterward, 10 ml of scintillation cocktail (Ecoscint H, National Diagnos-
tics, Atlanta, GA) were added. :Uld radioactivity was monitored in a {3-counter 
(LS-3800, Becknl:Ul. San R amon, CAl :Uld nonnalized with respect to 
glycemldehyde-3-phosphate-dehydrogenase. 
Western Blot Analysis Western blot analysis of PGHS-1 and -2 in 
fibroblasts treated with 10 U IL-l/3 per ml for the indicated periods of til11e 
was performed as described previously (Camacho et ai, 1995). PGHS-l 
isolated &0111 ram seminal vesicles and PGHS-2 purified &om sheep placenta 
were obtained from Cayman C hemical Co (Ann Arbor, MJ) . Rabbit 
polyclonal :Ultiserums against PGHS-l (PG 20) and PGHS-2 (PG 27) were 
fi'ol11 Oxford Biomedical Research, fnc. (Oxford , MI). 
Determination of PGHS Activity After cells had been cxposed to 10 
U IL-l {3 per ml fnr the desired period of time, they were incubated at 37°C 
in tile presence of 25 fLM [' 4C]arachidonic acid (['·C]-AA, 55-58 mCii 
mmol , Amcrsham Iberica) in 5 fLl of ethanol. After 15 min tile reactions 
were stopped by addition of a previously measured volume of 1 N HCl to 
yield pH 3 followed by one volume of cold l11etllanol. Samples were kept at 
-80°C until HPLC analysis. Analysis of prostanoids was performed as 
described previously (So]" et ai, 1992). 
Effect of PGHS Inhibitors on LA Metabolism Cells were preincu-
bated in the presence or in the absence of lOU IL-l {3 per 1111 for 24 h. 
Medium was removed, and cells were washed and treated with 1 ml of 
DMEM containing the indica ted concentrations of indomethacin or acetyl-
salicylic acid (ASA) dissolved in etllanol [final ethanol concentration , 0.1% 
(vol/vol)] for 10 min. ASA-treated cells were tllell washed twice with 
phosphate-buffered saline and incubated with [' 4ClLA as described above. 
Effect of the Inhibition of Protein Synthesis on the Action ofIL-l/3 
011 LA Metabolism The cells were incubated for 8 h witll lOU IL-l {3 per 
ml in the presence or in the absence of3 fLg cyclohc" .. imide per ml or 1 fLM 
actinomycin D (Sigma, St Louis, MO) . Fibroblasts were then incubated 
with 50 fLM ['·C]LA for 15 min as described above. 
Effect of Dexamethasone on the Action ofIL-l on ['4ClLA Metab-
olism Dermal fibroblasts were incubated for 8 h in the absence and ill ti,e 
presence of lOU IL-l ll per IIlI ,vith or without 10 n.M dex:Ullethasonc 
(Sigma). Cells were then incub<lted with 50 fLM ['·ClLA for 15 nun, <Ind the 
production of octadecaIloids was evaluated. 
Cell Fractionation Cells grown in 150-cn/ culture flasks wcre incu-
bated for 24 h witll 10 1111 of DMEM plus 1% (vol/vol) fetal bovinc serum 
in the presence or in the absence of lOU IL-l {3 per ml. Afterward, cells 
were washed with phosphate-buffered saline and detached with 5 ml of 
trypsin solution [0.1% (wt/vol) in phosphate-buffe red saline]. Cells were 
washed tv .. ice and centrifuged at 250 X g for 10 min, and the pelle t was 
resuspended in 1 ml of 10 mM Tris(hydroxymetllyl)-aminomcthane-H C I. 
pH 7.2. containing 0.1 % (wt/ vol) soybean trypsin inhibitor and protease 
inh.ibitors (1 mM sodium I1letabisulfite, 1. 111M bcnzamidine, 1 111M phenyl-
methylsul fonylfluoride, 1 mM ethylenediamine tetraacetic acid, and 1 mM 
etllylcneglycol bis(b-al11inoethyletller)-N,N,N ' ,N' -tetraacetic acid) . Cells 
were then disrupted m echanica lly with a Potter-Elvehjem homogenizer 
placed in an ice-water bath . Unfractionated cells were eliminated by 
centrifugation at 700 X g for 10 min, and the resulting supematant was 
centrifuged at 100,000 X g for 1 h at 4°C. The supernatant was collected. 
and till! pellet corresponding to the microsomal fraction was resuspended in 
the buffer mentioned above. The protein content. mcasu.red by the method 
of Lowry (Protein Assay Kit, Sigma), was adjusted to 1.67 mg per ml. 
Aliquots of 0.6 ml of cell &actions were then incubated with 50 fLM [' · ClLA 
plus 2 mM phenol at 37°C for 10 min. R eactions were stopped and 
octadecanoids were extracted and analyzed . 
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Figure 1. Fibroblasts produced two main products, S-I and S-II, 
with a chromatographic retention time identical to that of authen-
tic 13-HODE and 9-HODE, respectively. Representative SP-HPLC 
d~romatogram from a sample of dermal fibroblasts incubated with 50 f..tM 
[," ClLA for 15 min. Column: Vltrasphere-Si 4 X 250 mm , 5 f..tm , Beckman; 
solvent: diethyl ethcrill-hexanelacetic acid 30:70:0.1; Row rate: 1 mIl 
minute (Camacho et nl, 1995). 
Esterification of 13-HODE and 9-HODE into Phospholipids 
[1 4C] 13-I-IPOOE was obta ined by incubating [' ''C]LA with soybean lipoxy-
genase (Sigma). ["'C]13-HOOE waS purified "fter reduction of ['''C]13-
HPOOE with NaBH4 by co llecting the corresponding peak after SP-HPLC. 
[' 4C]9-I-IPOOE was obtained by incubating [14C]LA with tomato fruit 
homogenate according to the method described by Matthew el nl (1977). 
[14C]9-I-IPOOE was then reduced with NaBH4, and [' 4C]9-HODE was 
purifjed by SP-HPLC. Cells grown in 75-cm 2 culture Rasks , untreated or 
treated with IL-1 /3 for 24 h, were incubated in 2.5 ml of OM EM containing 
2% (vollvol) BFS and 2.5 f..tM [, 4C]13-I-IOOE or ["'C]9-I-IOOE for 3 h at 
37°C. Cells were washed with OMEM twice, after which 3 ml of2%, acetic 
acid in methanol and 3 ml of water WCre added to the Rasks, cells were 
scraped off the Rask, and lipids were extracted according to the method 
described by Bligh and Dyer (1959). Extracts were dried under a N , stream, 
and the residues were redissolved in 35 f..tl of methanollchloroform (1:2) 
and seeded in silica gel 1.50A thin- layer chromatography plates (LK50, 
Whatman, Maidstone, England). Chromatography was carried out as 
follows: a mixture of ethyl acetate:isooctane: acetic acid:water (55:25:10:50) 
was vigorously shaken and allowed to equilibrate for 15 min at room 
temperature, after which the upper phase was used as eluent. The phos-
pholipid fraction, remaining in the origin of the plate, was scraped off and 
extracted three times with 400 1 .. 1.1 of methanol:chloroform (1:2) . Extracts 
were dried lU1der an N 2 stream, redissolved in 35 f..tl of methanol : 
chloroform (1:2), and rechromatographed according to the method of Fine 
and Sprecher (1982). Plates were autorad;ographed at - 40°C for 72 h 
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(Autoradiography film Curix RP2, developer G138 from Agfa-Gevaert, 
Barcelona, Spain), and each spot was identified by comigratioll with 
authentic standards. Spots were scraped off, and the rad ioactivity was 
measured in a liquid scintillation co unter using Biogreen II as scintillation 
cockta il (Rcactivos Scharlau, Barcelona, Spain). Authentic ' ·C-Iabeled 
standards of phosphatidylcholine, phosphatidyl-cthanolamine, phosphati-
dylinositol, phosphatidyl-serine, and sphingomyelin wcre supplied by Am-
ersham Iberica. 
RESULTS 
The Main Octadecanoids Formed by Dermal Fibroblasts 
Were 9(R)-HODE and 13(S)-HODE The analysis of samples 
from incubations of fibroblasts with [14C ]LA by SP-HPLC revealed 
the presence of two major peaks (peak S-J and S- I1 Fig 1) that had 
the same retention times as authentic standards of 13-HODE and 
9-HODE. Occasionally, three minor additiona l peaks w ere ob-
served . 
To furth e r characterize the major compounds formed b y de rmal 
fibroblasts from LA, we coUected and derivatized the material 
eluting as the 13-HODE and 9-HODE fractions from SP-HPLC 
(peaks S-1 and SIl, respectively). Each purified compound was 
derivatized as the Me3 Si ether methyl ester and subsequently 
analyzed by GC-MS. The elec tron impact (El) mass spectrum of 
peak S- 1 (Fig 2) was essential ly identical to that previously reported 
for 13-HODE (Glasgow and Eling, 1990; Camacho el al. 1995), and 
the GC retention time and EY mass spectrum were identical to tho e 
of authentic I3-HODE. A molecular ion w as de tected at mass/ 
charge (m /z) 382 (M+ ). Additional informative ions were present 
at m/z 311 [M+-71 , loss of (CH2)4CH3] and 225 [M + -157, loss of 
(CH2hCOOCH3]' Similar ions occurred in the S-Il spectrum (Fig 
2), although the re lative intensiti es were different; the spectrum of 
tlus compound was identica l to those reported for 9-HODE 
(Glasgow and Eli.l1g, 1990; Camacho e/ ai, 1995) and to authentic 
9-HODE, GC retention time was also similar to that of authentic 
9-HODE. To determine the location of the hydroA],1 group, m ethyl 
esters were catalytically hydrogenated before trimethysilylether 
de rivatization . The EJ mass spectrum of saturated S-1 (Fig 2) 
contained major fragment ions at m /z 315 [M + -71 , loss of 
(CH2)4CH3] and 173 [M+ -213, loss of (CH 2 ) II COOCH3]. The 
fragment ion at m/z 315 suggested the location of the hydrox}'l 
g roup at C-13 and cleavage of the bond b e tween C-13 and C-14. 
The ion at m /z 173 also indicated the presen ce of a hydroA]'1 group 
at C - 13 and represents cleavage of the carbon boud between C-12 
and C-13. T he E1 mass spectrum of hydrogen ated S-I was essen-
tially identical to those reported for hydrogenated 13-HOOE 
(Glasgow and Eling, 1990; Camacho el al 1995) and authentic 
i3-HODE. The UV spectrum of peak S-J was identical to that of 
authentic 13-HODE and had a Am." value of 234-235, wluch 
revealed the presence of a conjugated cis,lralis-hydrm .. }, diene 
sys tem (Ingram and Brash, 1988). HPLC, GC- MS, and UV analysis 
indicates that peak S-I corresponded to 13-hydroxy-9-cis,l1-tralls-
octadecadienoic acid (13-HODE). 
The El mass spectrum of saturated S-1I (Fig 2) contained major 
fragment ions at mlz 259 [M -r -127 . loss of (CH2hCH 3] and 229 
~COOCHa 
225 I.l) 
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Figure 2 .. GC-MS analysis shows that the identity of S-I and S-II was 13-HODE and 9-HODE, respectively. Each purified compound \Va 
deriva ti zed as the trimcthylsilyl ether methyl ester and subsequently analyzed by GC-MS (S-I,pnuei A; and S-l1, pnucl q. Each purified compound was also 
derivatized as methyl es ter and subsequently ca ta lyti ca lly hydrogenated before trin1ethylsilyl derivatization. Elmass spectra from GC-MS analysis of saturated 
compounds are shown in jJnlleis Band D. T he schemes of fragmentation show the origin of the most characteristic fragments. 
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Figure 3. 9(R)-HODE and 13(S)-HODE were the main enantiomers 
fonne d by derntal fibroblasts. These arc representative dural phase 
I chromatograms of the methyl esters of standards and samples from un-
treated and IL-l ,l3-treated ce lls (10 U per ml for 24 h) incubated with 25 f..I.M 
['4C]LA for 10 min . Ratios of enantiomers arc shown in the text. 
[M+ -157, loss of (CH2hCOOCH3 j. The m ajor fragment ion at 
m/z 259 was consistent with th e loca tion of the hydrox)'l group a t 
C- 9 and cleavage of the bond between C-9 and C-10. The ion at 
m/z 229 also indicates that the location of the hydrox)'l group is 
C- 9, and fragm entation occurs b etween C-8 and C-9 . S-Il had UV 
spectrum identical to authentic 9-HODE with a A,,,,, ,, value of 
234 -235 , which indicated the presen ce of a conjugated cis, tmlls-
hydroA)' dien e system (Ingram and Brash , 1988) . HPLC, GC-MS, 
and UV analysis indica tes that this p eak corresponded to 9-hy-
I droxy-10-tmlls, 12-cis-octadecadienoic acid (9-HODE) . 
T h e analysis of the chirality of HODEs showed that 9 (R)-HODE 
1 and 13(S)-HODE were the maill enantiomers formed by dennal 
fib roblasts (Fig 3). T h e ratio between the enantiomers (S:R) 
forme d by fibroblasts w e re 3.55 ± 0.25 and 4.81 ± 0.81 fo r 
13-HODE; and 0 .26 ± 0.04 and 0.22 ± 0.02 (mean ± SD) for 
9-HODE, in untreated and IL-1/3-treated ceJls, respecti ve ly. 
PGHS Activity and PGHS-2 Expression Was Induced by 
, n.,...1/3 To observe the e ffec t oflL-1/3 on transcription ofPGHS-l 
and PGHS-2 gen es, cells were incubate d in the presen ce of lOU 
rL-l {3 pe r ml for several pe riods of time . Expression of specific 
mRNA encoding for PGHS-l and -2 was induced by IL-l/3 in a 
time-dependent m almer (Fig 4). Transcription of PGHS- l was 
slightly induced (2 .2-fold), w h creas PGHS-2 was dramatically 
induced by IL- l/3 (31-fold). The maximum levels ofPGHS mRNA 
were observed be tween 6 - 9 h of exposure to lL-1 {3 at lOU per 1111. 
T h e western blot analysis of the COX isoform s from m embranes 
of HUV-EC-C cells is shown in Fig 5. W e m easured th e time 
course of PGHS-l and PGHS-2 prote in expression by incubating 
I fibro blasts with 10 U IL-l{3 p er ml for various time inte rvals . No 
cross-reactivity was observed between PGHS-l antiserum and 
PGHS-2 protein isolated fro m sh eep placenta at th e con centrat ions 
used in this assay, and PGHS-2 antiserum did not recognizc 
PGHS-l prote in isolated from ram seminal vesicles. T h e antibody 
, against PGHS-l recognized a double band corresponding to the 
migration of purified PGHS-1. Apparently, no variation ofPGHS-l 
protein was produced as a function of time oftreatmcnt with IL-1 {3. 
In contrast, afte r IL-l{3 treatment there was a significant increase of 
PGHS-2 prote in expression in a tim e-dependent mann er with a 
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Figure 4. IL-IJ3 mainly induced transcription ofPGHS-2 gene. (A) 
Specific mRNA for PGHS-l and -2 expression normalized to glyceralde-
hyde-3-phosphate-dehydrogenase in human dermal fibrob lasts as a function 
of time of treatment with IOU IL-l f3 per ml; data are the mean of two 
separate experiments, quoted by individu,tl va lues; and (8) representative 
ge l photographs from polymerase chain reaction samples corresponding to 
the i.ndicated periods of time of treatment with IOU IL-l{3 per m1. 
m aximum between 9 and 24 h of exp osure to IL-1 {3, followed by 
a decrease at 48 h . The antibody against PGHS-2 peptide recog-
nized a m ajor band correspo nding to tlle migration of purifi ed 
PGHS-2 . 
In parallel exp eriments, PGHS activi ty as a fun c tion of duration 
of lL- l{3-treatment was evaluated as the pro duction of PGs after 
incubation of cells with 25 f.LM C ·ICJAA. The PGs de rived from 
C4 C]AA formed by fibrobl asts were PGE2 a.nd P G12 (determined as 
6-keto-PGF ,,,,) as th e major compo unds , and a lso minor amounts of 
106 ____ 
80--
18.5--
3 6 9 24 48 h 
Figure 5. IL-l{3 caused a time-dependent PGHS-2 expressioll in 
dermal fibroblasts. Upper pn"d, representative western blot ofPGHS-l of 
samples (65 f..I.g of protein) fro m cells incubated with lOU IL- l {3 per ml [or 
the indicated period of time. 80rrolll po"e!, representative western blot of 
PGHS-2 of the same samples as the "l'perl'n"c1. Purified PGHS-l (from ram 
seminal vesicles, 0.3 p.g) and PGHS-2 (fi'om sheep placenta, 0.3 f..I.g) were 
used as a reference. Location of the standards of molecular mass in 
ki lodaltons is indicated. Similar results were obtained with cell cxtmcts fi,oll1 
two difFerent batches of cells. 
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Figure 6. IL-l/3 caused a time-dependent increase ofPGHS activ-
ity in dermaJ fibroblasts. Cells were treated with 10 U IL-l/3 per ml for 
the indicated period of timc. Aftcrward, cells were incubated with 25 /LM 
[' ·'ClAA. PGHS activity is expressed as picomoles of["'ClAA transformcd 
into prostanoids (slim ofPGE2 , 6-keto-PGF, a, and PGF2,,) by 10(' cells in 15 
111in. Error bnrs. 111 ean :t SO; n = 4. 
PGF2 £> . PGHS activity estimated as the sum of the aforementioned 
PGs reached a maximum after 9 h of exposure to the cytokine and 
was sustained at least for 30 h (Fig 6). Twenty four hours of 
treatment with IL-l/3 was chosen to evaluate the effect ofIL- l/3 on 
LA metabolism in dermal fibroblasts. 
IL-t/3 Increased the Metabolism of LA in Human Dermal 
Fibroblasts Cells were incubated with different concentrations 
of IL-l/3 for 24 h and then incubated with [14C]LA as described in 
Materia ls alld Methods . Figure 7 depicts the synthesis of HODEs as 
a function of cytokine concentration, which achieved a maximum 
at 10 U IL-l/3 per m!. The ECso values ofTL-l/3 for 13-HODE and 
9-HODE formation were 3.2 ± 0.5 ,and 3 .4 ± 0.4 U per ml 
(me;tn ± SD), respectively, and quite similar to the ECso value for 
the sum of the aforementioned PGs (2.6 ± 0.4 U per 1111) . The time 
course of the production of LA m etabolites in cells treated with 
800 
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• 9-HODE 
600 .. PGs 
c 
'E 
U) 
:!:: 400 Q) 
U 
<D 
0 
..-
-0 200 E 
a. 
o 
0.01 0.10 1.00 10.00 100.00 
U/mIIL-1 ~ (log) 
Figure 7. IL-l/3 caused a parallel concentration-dependent in-
crease of PGs and HODEs biosynthesis by dermal fibroblasts. Cells 
were treated with IL-l/3 for several periods of time. Thcn cells were washed 
and incubated with 50 /LM ['4ClLA or 25 /LM ["ClAA for 15 min and the 
products formed were analyzed. The ECso value ofIL-l/3 was 3.2, 3.5, and 
2.6 U per ml for 13-HODE, 9-I-IODE, and PGs, respectively. En'Ol' bars, 
mean :t SO; n = 3. 
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Figure 8. 13-HODE and 9-HODE were formed in the first 5 min of 
incubation with ['''ClLA. Cells were incubated with and without 10 U 
IL-1 f3 per ml for 24 h and afterward incubated with 50 /LM ["'ClLA for the 
indicated periods of time. Points arc mean :t SD; 11 = 3. 
IL-l/3 at 10 U per ml and in untreated cells showed that the level 
of HODEs achieved a ma}';mum between 5 and 15 min of 
incubation, after which a decrease in the levels of 9-HODE was 
observed (Fig 8) during the next 60 min. 
Coincubation of cells with IL-l/3 and 3 J.l,g cycloheximide per mI, 
1 /LM actinomycin D, or 10 nM dexamethasone abolished the effect 
of IL-l/3 on oc tadecanoid synthesis. No effect of these inhibitors 
was observed on the production of HODEs by control cells or on 
cell viability determined by trypan blue dye exclusion . 
To demonstrate that the effect of IL-l /3 was mediated by PGHS, 
we incubated cells treated with IL-l/3 for 24 h with increasing 
concentrations of indomethacin and ASA pl;or to the incubation 
with C"C]LA as described in Materials n/ld Methods. Results in Fig 
9 showed a concentration-dependent inhibition of the synthesis of 
both 9-HODE and 13-HODE by the PGHS inhibitors. 
In order to determine the cellular location of the enzymatic 
activity responsible for the biosynthesis of HODEs, we performed 
experiments with fractionated cells. Microsomal (100,000 X g 
pellet) and cytosolic (100,000 X g supernatant) fractions were 
incubated separately with 50 J.l,M C4 C]LA. As shown in Table I , 
the synthesis of both 13-HODE and 9-HODE was mainly associ-
ated with the microsomal fraction. 
Distribution of Octadecanoids in the Different Classes of 
Cellular Phospholipids Fibroblasts untreated and treated with 
IL-l/3 for 24 h were incubated in the presence oflabeled HODEs 
as described in Materials alld Methods. Dermal fibroblasts incor-
porated both 9-HODE and 13-HODE into their phospholipids 
to a similar extent. The relative degree of incorporation of 
["4C]13-HODE and ['4C]9-HODE into the diffe rent classes of 
phospholipid in both untreated and IL- l/3-treated cells wa 
phosphatidylcholine > phosphatidyl-ethanolamine= sphingomye-
lin > phosphatidylinositol> phosphatidyl-serine. ResuJts in Table 
II indicate that IL-l/3 treatment significantly enhanced the ability of 
13-HODE to be incorporated into aU phosphoglyceride classe 
analyzed except sphingomyelin. The highest increase in the 13-
HODE esterification caused by IL-1/3 treatment was observed in 
phosphatidylinositol (2.4-fold). In contrast, no statistically signifi-
cant effect of IL-l /3 on 9-HODE incorporation into any phospho-
lipid class was observed. 
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Figure 9 . ASA and indomethacin (pGHS inhibito.rs) inhibited 13-
HODE and 9-HOOE biosynthesis by IL-lf3--treated fibroblasts . 
Fibroblasts were treated with IOU IL-l (3 per ml for 24 h and then incubated 
with [, 'ClLA in the presence of the indicated concentration of the drugs. 
n = 4, mean ± SO. lCso ofindomcthacin: 0.17 ± 0.04 and 0.13 ± 0.05 /-LM 
(mean ± SO) for 13-HODE and 9-HODE, respectively; ICS!) of ASA: 
102 ± 41 and 73 ± 36 /-LM (mean ± SO) for 13-HOOE and 9-HOOE, 
respectively. 
DISCUSSION 
Our findings demonstrate that human dermal fIbroblasts produce 
i3-HODE and 9-HODE as the main metabolites of LA. lL- l,8 
stimulates the synthesis of both compounds in a time and concen-
tration-dependent manner. 13-HODE may be synthesized through 
both the PGHS and the 1S-LO pathways, depending on the cell 
, type or tissue, whereas 9-HODE is produced enzymatica lly only by 
PGHS (Hamberg and Samuelsson 1967; Reinaud et "I, 1989; 
I Camacho et ai, 1995). Despite the fact that 1S-LO activity has been 
inferred to be present in dermal fibrob lasts (Mayer et ai, 1984; 
Kragba lle et al. 1986), experimental evidence supports the conclu-
, sion that PGHS-2 was the mam enzyme in volved in the increase in 
the formation of both 13-HODE and 9-HODE by IL-1,8: (i) The 
PGHS inhibitors, ASA and indomethacin , inhibited the synthesis of 
both 13-HODE and 9-HODE in IL-1J3-treated cells, and the 
recovery of 13-HODE and 9-HODE synthes is after ASA treatment 
(irreversible inhibitor of PGHS) showed a parallel recovery of 
13-HODE and 9-HODE (data not shown), which suggests a 
common enzymatic pathway; (ii) the ECso values of IL-l{3 for both 
13-HODE and 9-HODE were almost identica l, which also indi-
cates a common enzymatic pathway; (ill) the ratio of enantiomers of 
HODEs in controls and in IL-l,8 were quite similar to those 
obtained when HODEs are synthesized through isolated PGHS-l 
and PGHS-2, wh ereas isolated 15-LO yields strict S configuration 
Table I. 13-HODE and 9-HODE Were Mainly Produced 
by the Microsomal Fraction" 
13-HOOE 9-HOOE 
100,000 X g Controls 3.40 ± 4.8 7.16 ± IO.l 
supernatant IL-l !3 4.56 ± 9.5 5.50 ± 4.9 
100,000 X g Controls 55.4 ± 17.0 72.27 ± 13.2 
Pellet IL-l(3 174 .11 ± 19.2 253.03 ± 15.5 
• Fibroblasts fractio lls were incubated with 50 I'M ["'CJLA at 37' C for 10 min . 
Octadecanoids were extracted and nnalyzcd. Results arc expressed as picomoles of 
each C001POlll1d produced by milligrams ofpro[cin in to min. Mean ± SD. 11 = 4. 
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Table II. HODEs Were Mainly Associated to PhC and 
ll.-1{3 Increase the Esterification of 13-HODE Mainly 
into PhI" 
13-HODE 9-HOOE 
Controls IL-l!3 Controls IL-l !3 
Phi 2.78 ± 0.37 6.63 ± 0.95" 6.46 ± 1.07 5.98 ± 0.76 
PhS 2.58 ± 0.21 4.35 ± 0.28" 2.77 ± 0.47 3.96 :!: 0.98 
PhC J 08.3 ± 17.2 165.9 ± 15.59" 98.3 ± 3.75 11 7.8 ± 9.'1 
PhE 25.7 ± 3.96 40.9 ± 6.34" 34.4 ± 5.33 29.5 ± 6. 15 
SPh 28.0 ± 4.49 25.8 ± 5.19 21.8 ± 1.51 16.8 :!: 2.1 3 
I I Fibroblasts untreated and treated with IL-l {3 for 24 h were incubated wilh labeled 
HODEs for 3 h. and the radioactivity associated to the indicated phospholipid classes 
W:IS evaluated. RcsuJ u arc expressed as picomolcs ofll "CJHODE.~ incorporated in 3 h. 
Mean ~ SD. 1'1 = 4. 
II Significantly higher when compared with controls (p < 0.05) . Phi, phosphatidyl-
inositol: PhS. phosphatidylserine: PhC. phosphatidylcholine: PhE, phosphatidyleth-
al1olamin c; SPh. sphingomyelin. 
for 13-HODE (Camacho et nl, 1995); (iv) The subcellular localiza-
tion of the HODEs' biosynthetic activity was consistent with a 
PGHS activity rather than is-LO, because the latter is a cytosolic 
enzyme (Sigal ef ai, 1988) whereas PGHS is membrane-associated 
(Mori ta et ai, 1995); and finally, (v) the effect ofIL-i{3 on HODEs 
formation was well correlated with the dc 110110 expression of 
PGHS-2 and with the increase in the PGHS-activity. 
The presence of dexamethasone abolished the effect of IL-l,8 on 
the production of 13-HODE and 9-HODE. It has been suggested 
that dexamethasone may act on PGs' release by promoting the 
synthesis of a protein that inhibited the synthesis of the new PGHS 
induced b y IL-l (Raz cl ai, 1989). Our results are consistent with 
this explanation since dexamethasone abo lished the production of 
HODEs only in IL-l treated cells without affecting the production 
in nonstimulated cells (data not shown). 
HODEs, mainly 13-HODE, are present in high amounts in 
psoriatic lesions (Camp el ai, 1983; Baer el ai, 1990, 1991). Bacr el 
al (1991) had pointed out that the dural analysis of these com-
pounds agrees with a PGHS rather than with a i5-LO origin . Our 
results demonstrate that tlus occllrs in dermal fibroblasts and that 
this cell type ma y contribute to the HODEs detected in psoriatic 
lesions. T he effect of IL- l,8 on the stimulation of lA metabolism 
could also explain the high levels of these compou nds found in the 
inju red skin and suggests that all factors that increase the expression 
of PGHS-2 may act on fibroblasts by in creasing the synthesis of 
HODEs . Another point that supports the ro le of PGHS-2 in the 
biosYllthesis of HPODEs and HODEs is that LA is a substantially 
better substrate for PGHS-2 than for PGHS-l (Camacho et ai, 
1995). 
The ro le of LA-derived octadecanoids in inflammatory and 
proli ferative diseases is not clear. Nevertheless, a growing am ount 
of data suggest that octadecanoids derived from LA playa role as 
clements of signal pathways necessary for cell mitogenesis when 
stimulated by growth factors or oncogenic transformation. In 
particular, LA, HPODEs, and HODEs en hance the response of 
epithelia l cells and fibroblasts to insulin and epidemlal "Towth 
factor, respectively (Bandyopadhyay el nl. 1987; Glasgo: ct ai, 
1992) . T he proliferative effect of free hydropero>.:ides derived from 
LA is mediated by activation of a protein kinase in response to 
nutogens and c-fos, C-jllll, and C-IfII'C mRNA expression (Rao cr. nl, 
1995). 
In contrast, Miller et "I (1990) reported that 13-HODE reverses 
the epidermal hyperproliferation induced in essential fatty acids-
deficient conditions. Nevertheless, this activity seems to be related 
to the esterification of 13-HODE in the phospholipids mainly into 
phosphatidylcholine and phosphatidylinositol and the generation of 
13-HODE-containing diacylglycerol (Cho 'll1d Ziboh, 1994a), 
rather than with an activity of fi'ee 13-HODE by itself. This 
oxidized diacylglycerol inhibits epidermal protein kinase C isoen-
zymes, which are involved ill the regulation of cellul ar proliferation 
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(C ho and Z iboh , 1994b), and its activity is e levated in psoriasis, 
consi stent wi th the hi gh levels o f diacylgl ycero l (Fisher c/ ai, 1990) . 
T he prccise rol e o f oxidizcd phospholipids is unce rtain, but 
t 3-HODE was found to bc th e main hydroxy-fatty acid cs tcl-ificd in 
psoriatic scal es (Baer c/ ai, 1990, 1991). The fa ct that IL- J 13 may also 
in crcase the csterificatio n o f 13-H O DE ma y contributc to the hi gh 
Ic vcls of 13-HODE associ,lted with phospholipids fo und in skin 
Icsions. 
T he fa c t that oxidized LA modu latcs signa l transduction of thc 
mitogenic responsc and th at clcvatcd levcls of frec and cste rifi cd 
HODEs havc bce n found in samples from inAammatory prolifcra-
tivc diseases such as atherosclcrosis (lGinn e/ ai, 1992) and psoriasis 
(C amp e/ ai, 1983; Dacr c/ ai, 1990, 1991) sugges ts that these 
compounds play a ro le in the physiopathology o f such diseases . 
Although epidcrmal cc lls may synthesize 13-HODE (Nugtcren and 
Kivits , 1987) , th cl'c is no informatio n , as far as we know, con ccrn-
ing thc contribution of dermal tibroblas ts to thc HODEs pool found 
in the inAammatory lesioll s on skin . 
III 1/ ;110, thc limiting stcp for ocwdccanoid fo rma tion may bc the 
amount of frcc LA . T he high Ic vcls of thesc compollnds found in 
psoriati c lesions couJd be , in part, a consequ cnce of the stimu lation 
of their biosynth esis by cytokin es such as IL-l throug h the PGHS-2 
expression on skin cells includin g endo th elial (Camacho c/ ai, 1995) 
and epidermal ceUs (Scholz ct ai, '1995) or/ and of th e re lease of 
thosc pre viou sly esterified in m embrane lipids. Another source of 
13-HODE cou ld bc the I s -LO present in infiltratin g leukocytes 
(Sigal et ai , 1988) and epidermal cells (Nugteren and Kivits , 1987). 
Mo re studies are necded to assess the signifi cancc of th ese results ;11 
11;1/0, and th ese should in cludc studies of the effect of potent and 
sclectivc PGH S-2 selective inhibi tors, which are at prcsent being 
developed (Aslanian CI ai, 1994), 011 skin inAammatol'Y diseases . 
Th;s lIIork IIIns slipI'D/t ed I,l' n .~ r(l/It FOil! Itlsl;tlll de n eeercn ~r Ih" J-ISCSP, (llId 
DC ICYT PM92- 0'183 nud FIS 941 1559. w" w;sh til Ihnuk Ih .. sl~u'lIr Clrll;w 
Plnl/ as) Bn l'cr/mta , jor ,ltci,. rO lltrilJIII;OI1 of skill pieces, a"d to C ristina GerlJoll'i, 
Estlwr Cerlwl fs, nllli Rosn C n)'n Jill' their I .. (hu;enl nss;stnuce. 
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